Navigation Links
US Oncology Research Investigators Participated in Studies That Will be Presented at the 2010 American Society of Hematology Annual Meeting and Exposition
Date:12/3/2010

Nicholas Di Bella, M.D., oncologist for Rocky Mountain Cancer Centers – Aurora. "Using special gene expression technology, we can identify patients with lymphoma who are relatively resistant to standard therapy with R-CHOP. Patients with lymphoma with the non-germinal center B cell profiles may not respond to this combination, so these patients are being treated with standard R-CHOP or R-CHOP plus the new agent Bortezomib, which may overcome the natural resistance of lymphoma cells to R-CHOP."

Many clinical studies led by US Oncology Research Network physicians were also predominantly featured at numerous conferences held around the world, including the annual congress for the European Society for Medical Oncology (ESMO), the annual meeting for the American Society for Clinical Oncology (ASCO) and the upcoming San Antonio Breast Cancer Symposium (SABCS). Those studies, along with more than 30 published manuscripts, featured forward looking clinical research topics that are helping advance cancer care today and discover improved therapies for the cancer care of tomorrow. For a complete list, please contact US Oncology at 281-863-1000.

About US Oncology

US Oncology, Inc. is the nation's leading integrated oncology company. By uniting the largest community-based cancer treatment and research network in America, US Oncology expands patient access to high-quality care and advances the science of cancer care. Headquartered in The Woodlands, Texas, US Oncology is affiliated with 1,400 community-based oncologists, and works with patients, hospitals, payers, and the medical industry across all phases of the cancer research and delivery continuum. By promoting the use of innovative technology, clinical research, evidence-based medicine and shared best practices, U
'/>"/>

SOURCE US Oncology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Presentation of PROVENGE Data at the American Society of Hematology and the Society of Urologic Oncology Annual Meetings
2. Sagent Pharmaceuticals Adds to Its Oncology Portfolio With Launch of Topotecan Hydrochloride for Injection
3. Access Pharmaceuticals ProLindac™ and CobaCyte™ Oncology Research Displayed at the Innovations in Cancer Prevention and Research Conference, November 17-19, 2010
4. Generex Oncology Awarded Two IRS Therapeutic Discovery Project Grants
5. D3 Radiation Oncology Solutions has Completed Collaborative Commissioning of Two Varian TrueBeam Medical Linear Accelerators at the John Theurer Cancer Center, Hackensack University Medical Center
6. Elekta Introduces MOSAIQ Data Director, Image and Data Hub for Oncology
7. Philips Showcases Integrated Radiation Oncology Suite to Simplify Treatment Planning
8. Philips Introduces High Field Open MRI for Radiation Oncology
9. Accurays CyberKnife VSI System Featured at 2010 American Society for Radiation Oncology (ASTRO) Annual Meeting
10. D3 Launches New Suite of Solutions, including the First Radiation Oncology Clinical Pathways Program, at the ASTRO Annual Meeting, October 31 - November 3, 2010 in San Diego
11. Prostate Oncology Specialists Among First in the Nation to Treat Advanced Prostate Cancer Patients With PROVENGE
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/6mlrvg/an_introduction ) has ... to Medical Device Software: Regulations and Requirements (London, ... their offering. This course will ... requirements that apply to Medical Device Software. The ... examples and state-of- the-art practices identified from Notified ...
(Date:9/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/r6wspz/drug_delivery_in ) has ... "Drug Delivery in Central Nervous System Diseases ... offering. Advances in understanding of ... new avenues and possibilities for improved drug delivery ... enzymes, and receptors that control the penetration of ...
(Date:9/2/2015)... BOCA RATON, Fla. , Sept. 2, 2015 ... Cartledge , MD, FACS, has begun performing ultra-minimally ... patients who are on anticoagulants such as Coumadin, ... of Cardiothoracic Surgery at the Hospital, is one ... this method, which involves making two microscopic incisions ...
Breaking Medicine Technology:An Introduction to Medical Device Software: Regulations and Requirements Course - London, UK - November 2-3, 2015 2Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Report 2015-2024 2Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Report 2015-2024 3Boca Regional Introduces Ultra-Minimally Invasive Surgical Procedure for Atrial Fibrillation Patients 2Boca Regional Introduces Ultra-Minimally Invasive Surgical Procedure for Atrial Fibrillation Patients 3
... 2, 2010 CSA Medical, Inc. ( www.CSAmedical.com ) ... incoming president, CEO and member of the board of ... years of medical device experience, including market development roles ... "We are thrilled to have Bill join ...
... Dec. 2, 2010 Sagent Pharmaceuticals, Inc., a ... approval of four presentations of midazolam injection, USP, ... which will be offered in latex-free vials, in ... U.S. market for injectable midazolam approximated $52 million. ...
Cached Medicine Technology:CSA Medical Appoints William H. Floyd President and CEO 2Sagent Pharmaceuticals Announces FDA Approval of Midazolam Injection, USP 2
(Date:9/2/2015)... Athyn, PA (PRWEB) , ... September 02, 2015 , ... ... Heilman Hall at Bryn Athyn Church Elementary School, 600 Tomlinson Road, Bryn Athyn, Pa ... Inc., will host a day-long seminar featuring New York Times best-selling author Sam Keen ...
(Date:9/2/2015)... San Jose, CA (PRWEB) , ... September 02, ... ... connectivity for Internet of Things, announces its latest addition to its screen mirroring ... the existing award-winning Splashtop Extended Wireless Display, which operates in local WIFI setting, ...
(Date:9/2/2015)... ... September 02, 2015 , ... Michael Elliot Media announces ... a plus-size actress as the primary love interest in the film. The campaign is ... film, significantly affects how and what we think,” Michael Elliot, an award-winning screenwriter and ...
(Date:9/2/2015)... ... , ... Ericson is a noted speaker and educator in the field of ... Education for the Association for Clinical Documentation Improvement Specialists (ACDIS) where she developed and ... serves as a CDI subject matter expert for a variety of HCPro and ACDIS ...
(Date:9/2/2015)... ... September 02, 2015 , ... A recent survey by Consumer Reports ... year and its negative impact on consumers. It was reported that 33% are paying ... paying as much as an extra $100 compared to last year. Among the drugs ...
Breaking Medicine News(10 mins):Health News:justCommunity, Inc. and Bryn Athyn Men’s Groups Present Workshop on Family Reconciliation 2Health News:Splashtop Launches Wired XDisplay, the Fastest Screen Sharing Solution for Extending and Mirroring Your Computer Screen to Mobile Devices 2Health News:Splashtop Launches Wired XDisplay, the Fastest Screen Sharing Solution for Extending and Mirroring Your Computer Screen to Mobile Devices 3Health News:Award-Winning Screenwriter Uses Crowdfunding Campaign to Change Hollywood’s Ideal of Beauty to Include PLUS-SIZE Women 2Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 2Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 3Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 4Health News:Watertree Health President Responds to Consumer Reports Survey on Rising Prescription Drug Prices 2
... data from a Phase 2 clinical trial of GVAX ... Johns Hopkins Sidney Kimmel Cancer Center. The trial ... GVAX after surgical resection of their tumor and adjuvant ... patients was previously reported to be 26.8 months, a ...
... end, even if it is all subtle, as in Canada ... pin down is more dangerous to mental health than ... living in Canada. ,"We found that the subtle ... such as symptoms of depression and anxiety," said lead author ...
... Annual Meeting of SNM, the world's largest society ... German researchers stated that early metabolic imaging with ... to chemotherapy for esophageal cancer. ,"This ... from early metabolic response assessment to clinical decision ...
... announced today that HHS has awarded a contract for $500 ... manufacture and deliver 20 million doses of a next generation ... would be recommended in the event of a smallpox outbreak ... immune systems. The full supply of the vaccine will be ...
... welcomed a new study to be published today in ... contribute to the steadily mounting evidence that undermines ... obesity. A report issued last Friday by the Federal ... Archives study found that "children do not currently see ...
... interim findings from its Phase II, multi-center clinical ... anthracycline currently in development for the treatment of ... indicate favorable interim results in terms of response ... current treatment standard, topotecan, in second-line treatment of ...
Cached Medicine News:Health News:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer 2Health News:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer 3Health News:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer 4Health News:Koreans in Canada Feel Put Down by Subtle Racism 2Health News:Esophageal Cancer Patients' Positive Responses to Chemotherapy Accurately Identified by PET 2Health News:HHS Buys Next Generation Smallpox Vaccine 2Health News:HHS Buys Next Generation Smallpox Vaccine 3Health News:New Studies: Commercials Aren't Making Kids Fat 2Health News:Amrubicin Shows Encouraging Results for Small Cell Lung Cancer Treatment 2
Trial Lens Sets....
Magnets move the color disks, Protects Disks from fingerprints, Keeps all the disks in one place, Clear glass insures accurate color perception, Makes Color testing fun....
Solo-care is a multi-purpose solution for cleaning, rinsing, disinfection and storing soft contact lenses....
... Multi-Purpose Solution for cleaning, rinsing, disinfecting, ... loosens and removes accumulations of film, ... lenses. Destroys harmful micro-organisms on the ... and rewets lenses before insertion. Renu ...
Medicine Products: